Lexaria Bioscience Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INVENOMIC CAPITAL MANAGEMENT LP | 05/15/2026 | 442.30 K | $345.00 K | -6.08% | 1.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 294.16 K | $229.47 K | 33.88% | 1.20% |
| 05/15/2026 | 222.29 K | $173.39 K | 100.00% | 0.91% | |
| TORONTO DOMINION BANK | 05/15/2026 | 140.01 K | $109.28 K | 0.00% | 0.57% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 94.17 K | $73.45 K | 100.00% | 0.39% |
| UBS GROUP AG | 05/05/2026 | 52.71 K | $41.11 K | -85.41% | 0.22% |
| STATE STREET CORP | 05/15/2026 | 39.30 K | $30.66 K | 0.00% | 0.16% |
| BLACKROCK, INC. | 05/13/2026 | 27.45 K | $21.41 K | 0.00% | 0.11% |
| XTX TOPCO LTD | 05/15/2026 | 25.07 K | $19.55 K | 100.00% | 0.10% |
| VONTOBEL HOLDING LTD. | 05/08/2026 | 23.00 K | $17.94 K | 100.00% | 0.09% |
| KRILOGY FINANCIAL LLC | 04/17/2026 | 19.65 K | $19.36 K | 0.00% | 0.08% |
| HRT FINANCIAL LP | 05/14/2026 | 18.47 K | $14.00 K | 100.00% | 0.08% |
| NORTHERN TRUST CORP | 05/14/2026 | 18.39 K | $14.34 K | 0.00% | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 16.30 K | $12.71 K | 4.49% | 0.07% |
| BANK OF MONTREAL /CAN/ | 05/13/2026 | 14.03 K | $10.95 K | -0.36% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2026 | 13.51 K | $10.54 K | 100.00% | 0.06% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 10.20 K | $7.96 K | 100.00% | 0.04% |
| 05/08/2026 | 10.00 K | $7.80 K | 100.00% | 0.04% | |
| ROYAL BANK OF CANADA | 05/15/2026 | 7.14 K | $6.00 K | -1.96% | 0.03% |
| BYRNE ASSET MANAGEMENT LLC | 04/02/2026 | 800 | $624 | -99.24% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 605 | $471 | -72.44% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 489 | $381 | 100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 382 | $298 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 166 | $144 | 0.00% | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 05/01/2026 | 13 | $10 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 3 | $2 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 2 | $2 | -93.75% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 1 | $1 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lexaria Bioscience Corp institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Lexaria Bioscience Corp. The most heavily invested institutionals were:
Invenomic Capital Management LP: 442,301
GEODE CAPITAL MANAGEMENT, LLC: 294,157
TORONTO DOMINION BANK: 140,013
VANGUARD FIDUCIARY TRUST CO: 94,166
UBS Group AG: 52,708
STATE STREET CORP: 39,301
6.10% of Lexaria Bioscience Corp stock is owned by institutional investors.
Institutional investors have bought a total of 1.59 M shares in the last 24 months. This purchase volume represents approximately $1.16 M in transactions.